New smartphone test to ‘revolutionise’ type 2 diabetes prevention

PocDoc, a leading UK digital health diagnostics company, has launched what it says is the world’s first smartphone-based test for type 2 diabetes risk including the gold-standard blood biomarker, HbA1c, a landmark step in diabetes prevention according to the company.

The new test follows the success of PocDoc’s flagship product, the “Healthy Heart Check”, an at-home finger-prick test for cardiovascular disease (CVD). With the “Healthy Heart Check” having established itself as the most widely used CVD screening test in communities, workplaces and homes in the UK and set to be the best-selling test since COVID according to PocDoc, the company is now targeting diabetes prevention.

Type 2 diabetes has been on the rise in the UK. Around 5.2 million people in the UK have been diagnosed with the condition according to Diabetes UK, and a further 1.3 million are undiagnosed. This has put a significant financial strain on the healthcare system, costing the NHS over 8.8 billion GBP, with studies suggesting that the annual cost of the disease could increase to 16.9 billion GBP in the next 25 years.

Sign up for Blog Updates